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Abstract
Octopine dehydrogenase (OcDH) from the adductor muscle of the great scallop, Pecten maximus, catalyzes the NADH
dependent, reductive condensation of L-arginine and pyruvate to octopine, NAD
+, and water during escape swimming and/
or subsequent recovery. The structure of OcDH was recently solved and a reaction mechanism was proposed which implied
an ordered binding of NADH, L-arginine and finally pyruvate. Here, the order of substrate binding as well as the underlying
conformational changes were investigated by NMR confirming the model derived from the crystal structures. Furthermore,
the crystal structure of the OcDH/NADH/agmatine complex was determined which suggests a key role of the side chain of
L-arginine in protein cataylsis. Thus, the order of substrate binding to OcDH as well as the molecular signals involved in
octopine formation can now be described in molecular detail.
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Introduction
Several molluscan species, in particular cephalopods are
known for their vivid swimming performances. Also among the
usually slow moving or even sedentary bivalves, active species are
known such as the Pectinid scallops which exhibit jumping and
swimming movements when attacked by predatory starfish [1].
The valve clapping movements shown during escape response are
powered by a single valve adductor muscle, the scallop, which
derives ATP for this strenuous muscle activity mainly from trans-
phosphorylation of phospho-L-arginine and to a lesser extent by
anaerobic glycolysis. Already during escape response or subse-
quent recovery the animals restore the phospho-L-arginine pool
using anaerobic glycolysis which is terminated by the formation
of octopine, a reaction catalyzed by the octopine dehydrogenase
[2]. This enzyme received considerable interest in the past,
mainly because of its analogy to lactate dehydrogenase (LDH).
However, the reaction mechanism seems to be different in both
enzymes.
Octopine dehydrogenase (OcDH, N
2-(D-1-carboxyethyl)-L-
arginine:NAD
+-oxidoreductase, EC 1.5.1.11) catalyzes the reduc-
tive condensation of L-arginine and pyruvate in the presence of
NADH to yield D-octopine [(R)-N
2-(1-carboxyethyl)-L-arginine],
NAD
+, and water (Figure 1). This enzyme was first discovered in
1959 by van Thoai and Robin in extracts from the adductor
muscle of the great scallop, Pecten maximus (P. maximus) [3]. It has
also been found in muscle tissue of many other marine as well as in
some limnic invertebrates [4].
OcDH synthesizes octopine during escape or when recovering
from exhaustive, anaerobic muscle work. Octopine can, therefore,
be considered like lactate as an end product of anaerobic glycolysis
in many animals [4].
During the last 50 years, the enzymatic characteristics of OcDH
from the adductor muscle of P. maximus have been extensively
studied and numerous basic informations have been published
[5,6,7,8]. Recently, cloning and heterologous expression of OcDH
from P. maximus were accomplished [9] and the crystal structures
of OcDH in complex with NADH, NADH/L-arginine as well as
NADH/pyruvate were reported [10]. The biochemical charac-
terization underlined the substrate specificity of OcDH since next
to L-arginine only L-cysteine and L-alanine can be used as a
substrate for OcDH from the pool of all natural amino acid tested.
However, the activity for the latter two amino acids is severely
reduced (1.2% for L-cysteine and 0.3% for L-alanine, respectively)
[10].
Despite the physiological, biochemical and structural informa-
tion available for OcDH from P. maximus, controversial discussions
about the kinetic reaction mechanism remain. Deduced from
kinetic analyses, two mechanisms for the OcDH-catalyzed
reaction have been proposed. Baici et al (1974) proposed, based
on kinetic and fluorometric data, that the apo enzyme forms a
binary complex in the presence of NADH to which the other two
substrates bind in a compulsory ordered sequential mechanism
[11]. This step should result in the formation of a Schiff base. The
subsequent hydride transfer from NADH to the Schiff base
reduces this transient intermediate to D-octopine. In contrast,
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mechanism. After the formation of the binary OcDH/NADH
complex, L-arginine and pyruvate are supposed to bind randomly
[12]. Thus, it is still uncertain up to now in which order the
substrates bind to the enzyme before the product D-octopine is
formed.
Recently, the crystal structure of OcDH from Pecten maximus was
solved [10]. The enzyme consists of two domains, an NADH
binding domain and a so-called octopine-binding domain. The
latter one forms a helix-kink-helix motif located at the L-arginine
binding site. Furthermore, a catalytic dyad comprising a His–Asp
proton relay system and an additional Arg-sensor (Arg324) were
identified. From these crystal structures, a sequential order of
substrate binding was postulated. NADH is bound to the
Rossmann fold motif localized in domain I. This triggers an
interaction of Arg324 (domain II) with the pyrophosphate moiety
of NADH. Thereby a stable conformation of OcDH is secured
which allows L-arginine to bind. As last substrate pyruvate binds
and is immediatle condensated with L-arginine resulting in
octopine formation.
We like to stress that in the crystal, domain I and domain II are
stabilized in the presence of NADH by two different sets of
interactions. First, Arg324 located in domain II binds the
pyrophosphate moiety of NADH bound to domain I thereby
acting as a ‘‘NADH-sensor’’. This already closes the protein.
Second, the His-tag located in the cleft of both domains clues
together these two parts. Through this sort of artificial arrange-
ment, the pyruvate binding site is generated that would not be
present in solution [10], This allowed us to solve the structure of
OcDH/NADH-pyruvate which in solution is not observed.
Thus the formation of the OcDH/NADH complex should
precede the binding of L-arginine, which then induces a rotational
movement (via the helix-kink-helix motif) of the two domains
towards each other. This movement coordinates the placement of
the a-ketogroup of pyruvate and the a-amino group of L-arginine
in close proximity to each other resulting in the subsequent
formation of a Schiff base which is immediately reduced to D-
octopine and thus prevents the reduction of pyruvate to lactate.
The formation of the latter has never been observed in P. maximus,
which indicates that pyruvate binding to OcDH does not occur
spontaneously.
Such a conformational change has also been proposed for the
Saccharopine Dehydrogenase from Saccharomyces cerevisiae, which
catalyzes the reversible pyridine nucleotide-dependent oxidative
deamination of saccharopine to yield L-lysine and a-ketoglutarate
(a-KG) [13]. This reaction, in principle, corresponds to the
backward reaction of OcDH. Here, the binding of saccharopine is
suggested to induce a conformational change, which brings the
two domains closer together, narrowing the active site cleft. This
positions the cofactor NADH and the substrate in close proximity
allowing hydride transfer by NADH [13].
In solution, however, no activity can be observed when pyruvate
is added as a substrate to OcDH in the presence of NADH. Such a
reaction could possibly generate lactate in analogy to lactate
dehydrogenase. However, the crystal structures of OcDH revealed
that the conformational change observed by L-arginine binding is
a prerequisite to form the pyruvate binding site [14]. Despite the
new information derived from the crystal structures of OcDH, the
following additional questions still remain enigmatic: (I) Is the
order of formation of a ternary OcDH/NADH/L-arginine
complex inducing conformational changes in aqueous solution?
(II) Is the side-chain of L-arginine dictating these conformational
changes?
Here, we have applied two different methods, nuclear magnetic
resonance (NMR) and X-ray crystallography to address these
questions.
Materials and Methods
All chemicals used were of analytical grade and were used
without further purification. NADH and NAD
+ were obtained
from Roche, pyruvate L-arginine and agmatine from Sigma.
Cloning of the OcDH gene, heterologous, large scale expression
and determination of enzymatic activity of OcDH, were
performed as described previously (Mueller et al, 2007; Smits
et al, 2008b).
Figure 1. Chemical structures A) Reaction scheme for the reductive condensation of pruvate and L-arginine mediated by OcDH. B)
Chemical structure of agmatine.
doi:10.1371/journal.pone.0012312.g001
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Expression and purification of isotope labeled OcDH-His5: For
the expression of U-[
15N] labeled OcDH M9 Minimal media
(0.6% (w/v) Na2HPO4, 0.3% (w/v) KH2PO4, 0,05% (w/v) NaCl,
0.4% (w/v) Glucose, 1 mM MgSO4, 0.3 mM CaCl2,1mgm L
21
Biotin, 1 mgm L
21 Thiamin, 50 mgm L
21 EDTA 8,3 mgm L
21
FeCl3, 0.84 mgm L
21 ZnCl2, 0.13 mgm L
21 CuCl2, 0.1 mgm L
21
CoCl2, 0.1 mgm L
21 H3BO3,1 6 n gm L
21 MnCl2, pH 7.0)
supplemented with 0.1% (w/v)
15N-ammoniumchlorid as only
nitrogen source was used. Five liter minimal media were
inoculated with an over night culture and cells were grown for
12 h at 37uC. Cells were then induced by the addition of 0.35 mM
IPTG and the expression temperature was lowered to 18uC for
another 36 hours. Purification was performed as described before
[9] and finally OcDH was dialysed against 50 mM Na-phosphate
buffer pH 6.8, 1 mM DTT and 1 mM EDTA.
NMR experiments
Expression and purification of U-[
15N] labeled OcDH was
carried out as described above. NMR samples for titration
experiments contained 0.25 mM U- [
15N] labeled OcDH in
aqueous solution (50 mM potassium phosphate, pH 6.8, 1 mM
EDTA, 1 mM DTT and 6% (v/v) 2D2O). All NMR experiments
were carried out at 298 K on a Varian UnityINOVA
spectrometer, equipped with a 5 mm cryogenic Z-axis PFG-1H
triple resonance probe at a proton frequency of 800 MHz. For
each concentration of ligands a 2D TROSY-type [15]
1H-
15N
correlation experiment was recorded with 69 ms maximum 15N
evolution time and 16 accumulated scans t1 per time increment.
The concentration of NADH was increased from 75 mMt o3m M
in 6 steps, NAD
+ from 75 mM to 5 mM in 7 steps and L-arginine
from 75 mM to 8 mM in 6 steps with 3 mM NADH present in all
steps.
Spectra were processed using the Varian VNMRJ 1.1D
software and analyzed with the program CARA [15]. For
determination of dissociation constants the incremental shift of
individual resonance peaks were extracted as vector lengths from
each series of titration spectra and subsequently plotted against
ligand concentration. Curves were fitted to following equation
(one-site saturation model):
Dd =( Ddmax ? [L])/(Kd + [L]).
Here, Kd is the dissociation constant, [L] the ligand
concentration, Dd is the change of the chemical shift, Ddmax
Table 1. Refinement statistics of the ODH/NADH-agmatine complex.
Crystal parameters at 100 K Agmatine (NADH)
Space group P41212
Unit Cell parameters
a=b ,c( A ˚) 96.2,96.2 117.4
a,=b= c (deg.) 90.0
Wavelength (A ˚) 0.8148
Resolution (A ˚) 20–2.8 (3.0–2.8)
Mean redundancy 4.4 (4.5)
Unique reflections 11968 (2282)
Completeness (%) 90.0 (92.5)
I/s 13.6 (4.5)
Rsyme
a 10.3 (36.3)
Refinement
R-factor (%) 21.1 (32.2)
Rfreec (%) 26.5 (36.3)
rmsd from ideal
Bond lengths (A ˚) 0.09
Bond angles (deg.) 1.23
Average B-factors (A ˚2) 28.48
Ramachandran plot
Most favored (%) 98.2 (396 residues)
Allowed (%) 1.8 (7 residues)
Generously allowed (%) 0
Disallowed (%) 0
Model content
Monomers/ASU 1
Protein residues (start methionine is not visible) 2–404
Ligand 1 NADH, 1 Agmatine
Refinement statistics were obtained from REFMAC5 [17] and Ramachandran analysis was performed using PROCHECK [28].
aRsym is defined as
Rsym~
P
hkl
P
i
Ii hkl ðÞ {SIh k l ðÞ T jj
 P
hkl
P
i
Ii hkl ðÞ and RF asb Rf~
P
hkl Fobs jj { Fcalc jj jj
 P
hkl Fobs jj .R free is calculated as RF but for 5% randomly chosen reflections that
were omitted from all refinement steps.
doi:10.1371/journal.pone.0012312.t001
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resonance.
X-ray crystallography and structure determination
As it was not possible to obtain crystals of the OcDH/NADH-
agmitine complex we used soaking to obtain the agmatine bound
OcDH structure. This means that OcDH protein crystals were
transferred into a solution containing agmatine, which diffuses into
the crystal and is specifically bound. Therefor crystals of OcDH-
His5 were grown as described previously [10]. In brief, crystals
grew by mixing protein solution (20 mg mL
21) with reservoir
solution, (100 mM MES pH 6.0–7.0) and Na-citrate ranging from
1.0 to 1.2 M, in a 1:1 ratio. Crystals appeared after approximately
5 days. Prior to crystallization, 0.8 mM NADH was added to the
protein solution. Agmatine-bound crystals were obtained by
soaking NADH-bound OcDH crystals in 100 mM MES pH 7.0,
1.15 M Na-citrate, 0.8 mM NADH containing 20 mM agmatine
for at least 8 hours. Suitable crystals were washed in 100 mM
MES pH 7.0, 30% (v/v) ethylene glycol, 1.15 M Na-citrate and
directly frozen in liquid nitrogen.
Data collection and structure determination
A dataset of OcDH/NADH/agmatine at 2.8 A ˚ was collected at
beamline BW7A, EMBL, DESY, Hamburg (Germany). Detailed
information on data collection statistics are shown in Table 1. The
dataset was processed with the XDS program package [16] and
phased and refined by rigid body refinement using the OcDH/
NADH/L-arginine structure as template (PDB code: 3C7C) and
further refined using REFMAC5 [17] and COOT [18]. Dataset
and refinement statistics are summarized in Table 1. The final
OcDH/NADH-Agmatine structure was compared with the
OcDH/NADH complex by superimposing both structures. Here
domain I (NADH binding domain) was used as ankerpoint.
Figure preparation
Structure figures were prepared using PyMol (http://pymol.
sourceforge.net/).
Results
Substrate induced chemical shift changes observed by
NMR spectroscopy
Solution NMR spectroscopy was applied as an independent
approach to verify the results from X-ray crystallography [10]. An
advantage of solution NMR compared to X-ray crystallography is
that all measurements are performed in aqueous solution. No
crystals are required to investigate substrate binding. Furthermore,
NMR not only provides insights into the thermodynamics of
ligand binding, but it is also well suited to detect structural
rearrangements upon ligand binding. Therefore, a series of protein
heteronuclear single quantum coherence (HSQC) spectra were
recorded with increasing concentrations of ligand in the sample,
also called ‘‘HSQC titration’’ [19]. If a full sequence specific
assignment of the HSQC resonances is present and a three-
dimensional solution structure of the protein, HSQC titrations
allow mapping of the ligand-binding site onto the protein surface
and provide insights into the thermodynamics of ligand binding,
possibly the mode of binding, and in favorable cases even the
dissociation constant of the protein–ligand complex [19,20].
To perform HSQC-titrations, OcDH was uniformly isotope
labeled by using
15N-ammonium chloride as the sole nitrogen
source during heterologous expression of OcDH in E. coli.
15N-
labeled OcDH was then used to record 2D
1H-
15N-TROSY-
HSQC spectra of the enzyme. The resolution and spatial
dispersion of the
1H-
15N cross peaks were excellent, 367 separated
backbone
1H-
15N cross peaks could be detected, which was well in
accordance with the expected number of resonances for OcDH
(399 residues). We used this spectrum as a reference for the
detection of chemical shift perturbations caused by binding of
NADH, L-arginine and/or pyruvate.
Unfortunately, we were not able to establish full assignments
due to poor deuterium to proton back-exchange of the per-
deuterated and
13C-
15N-labelled OcDH NMR sample. About
25% of the backbone amides did not exchange with H2O even
under denaturing conditions. Here, suitable refolding procedures
for OcDH after full deuterium to proton back-exchange under
denaturating conditions could not be established.
Nevertheless, for binding studies, NADH was first titrated to
15N-labeled OcDH with increasing concentrations of NADH
ranging from 0.075 mM to 3 mM (Figure 2a) and 2D-TROSY-
HSQC spectra were recorded at each concentration. Superposi-
tion of the
15N-
1H-TROSY spectra of the apo-enzyme and the
OcDH/NADH complex revealed that several peaks shifted to
different resonance frequencies, which were directly correlated to
the NADH concentrations. The measured differences of the
chemical shifts of at least five randomly selected peaks were used
for the calculation of dissociation constant (Kd) for NADH
(Figure 3). Applying a single binding site fit a KD =0.0626
0.007 mM for NADH was determined. For NAD
+ a KD of
0.460.05 mM was obtained (Figure 2b and 3b). In the absence of
NADH superposition of
1H-
15N-spectra recorded after titration
of L-arginine as well as pyruvate to the [
15N]-OcDH solution did
not yield chemical shift perturbations of cross peaks (data not
shown). This suggests that NADH is the first substrate to bind to
OcDH.
Since no shifts of amide cross peaks had been observed with
either L-arginine or with pyruvate in the absence of NADH,
OcDH was saturated with 3 mM NADH prior to titration of one
of these substrates. Further addition of pyruvate up to 10 mM did
not result in any shift of amide cross peaks (data not shown).
However, when the OcDH/NADH complex was titrated with L-
arginine in concentrations ranging from 0.075 mM up to 8 mM,
superposition of the spectra revealed a large number of resonance
peaks being shifted. The dependence of the respective chemical
shift differences of the L-arginine enabled us to calculate a KD
value of 4.160.31 mM for the binding of L-arginine to the binary
OcDH/NADH complex (Figure 1c and 2c). These values
obtained by NMR (Table 2) are in good agreement with reported
Kd’s [11]. Furthermore, it strongly suggests that L-arginine is the
second substrate to bind to OcDH as postulated recently [10].
In addition, chemical shift changes in general indicate different
chemical environment of the respective nuclei. The chemical
Figure 2. Superposition of (
1H-
15N) TROSY-HSQC-spectra of OcDH-His5 after titration with different substrate concentrations. The
spectra were collected at 296 K at a proton resonance of 800 MHz. The initial protein concentration was 0.25 mM. A) NAD
+ titration. The NAD
+
concentration was raised in seven steps from 0.075 mM (blue line) to 5 mM (black line). B) NADH titration. The NADH concentration was raised in six
steps from 0.075 mM (blue line) to 3 mM (black line) C) L-arginine titration. NADH was added prior to titration at a concentration of 3 mM. The L-
arginine concentration was raised from from 0.075 mM (blue line) to 8 mM (black line). Black arrows indicate the resonances which movements were
used for the calculation of the dissocation constant.
doi:10.1371/journal.pone.0012312.g002
Conformational Change in OcDH
PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12312environment can change due to direct interaction with the
substrate or due to substrate binding induced conformational
changes, even minor ones. The sheer number of chemical shift
changes in the finger print region upon L-arginine binding
indicates that much more residues are affected upon substrate
binding as could be explained by a sole and physical interaction of
the protein with the substrate. Thus, L-arginine binding obviously
induced conformational changes in OcDH. What induces
the conformational change of OcDH upon L-arginine
binding?
Agmatine is the decarboxylation product of arginine (see the
chemical structures in Figure 1). This molecule obviously opens
the possibility to dissect the individual influence of the a-
carboxylate moiety and the side chain of L-arginine. Using
agmatine in activity assays instead of L-arginine revealed no
activity. Two possible reasons can explain this lack of activity.
Either agmatine is not binding or the carboxyl group, which is
present in L-arginine but not in agmatine, is crucial for the
condensation reaction. To distinguish between the two scenarios,
inhibition studies were performed (Figure 4). The evaluation of the
data clearly demonstrates that agmatine acts as a competitive
inhibitor with a Ki of 4062 mM. This implicates that agmatine
and L-arginine bind to the same binding site in OcDH.
Consequently, we were wondering if the binding of agmatine is
inducing a similar conformational change in OcDH as L-arginine
as observed in NMR (reported here) and X-ray studies [10]. Since
no sequence assignment could be established in the NMR
experiments, we solved the structure of the OcDH/NADH-
Agmatine complex by X-ray crystallography. This structure
should give an answer whether or not a domain closure is induced
by the side chain of agmatine or by the functional important
coordination of the carboxyl group of L-arginine by His212. A
2.8 A ˚ dataset was collected and initial phases were obtained by a
rigid body refinement with the OcDH/NADH-pyruvate structure
as template. The structure was further built using COOT [18] and
several rounds of refinement using REFMAC5 [17]. Dataset
statistics and refinement statistics as well as final model contents
are summarized in Table 1.
The overall structure of the complex is provided in Figure 5a.
The structure of OcDH/NADH-agmatine appears more closed
than the OcDH/NADH structure (Figure 5a). Here domain I, the
NADH binding domain, was used as an ankerpoint as no
structural rearrangements where observed inside this domain. As
described above the his5-tag of OcDH is crucial for crystallization
[14]. It is protruding into the cleft of both domains thereby locking
OcDH in a conformation enabling crystal contact formation. In
Figure 3. Determination of the dissociation constant of NADH
(A), NAD
+ (B) and L-arginine (C). Plotted are the normalised
chemical shifts of specific amid resonances at different substrate
concentrations.
doi:10.1371/journal.pone.0012312.g003
Table 2. Dissociation constants of substrate binding to
octopine dehydrogenase.
NMR Literature (11)
titration experiment Kd Kd
(mM) (mM)
NADH in OcDH 0.06260.007 0.020
NAD
+ in OcDH 0.460.05 0.38
L-arginine in OcDH + NADH 4.160.31
Pyruvate in OcDH + NADH N.b.d
The dissociation constants for NADH, NAD
+, L-arginine as determined by NMR
as well as the values derived from the literature are reported. ‘‘N.b.d’’: no
binding detectable under the experimental set-up.
doi:10.1371/journal.pone.0012312.t002
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differently as in the OcDH/NADH complex (Figure 5b).
This conformational change is only observed when the agmatine
soak into the OcDH/NADH complex crystals was successful
and agmatine was bound to OcDH. This indicates that the
reorientation is a consequence of agmatine binding to the OcDH/
NADH crystals.
Already during the initial round of refinement after rigid body
refinement and manual building it became obvious that agmatine
is bound inside the structure in a fashion similar to L-arginine in
the OcDH/NADH-L-arginine complex (Figure 5C). The guani-
dinium headgroup of agmatine is coordinated via interactions with
the side chains of Glu142 (domain I) and Trp278 (domain II) as
well as backbone interactions with Met206 (domain II). The Cb
atom is bound via backbone interactions of Ser207. The density of
agmatine is of reasonable quality. However, at a comparable
resolution to the OcDH/NADH-L-arginine complex, the density
is not of the same quality than the density of L-arginine. This
suggests that agmatine is bound inside the crystal less well than L-
arginine.
However, the binding of agmatine induces a similar rotational
movement of domain II towards domain I (Figure 5a), which is
almost identical to the domain closure observed in the OcDH/
NADH-L-arginine structure [10]. This is reflected in the RMSD
value between the L-arginine and agmatine structure is 0.6 A ˚ over
399 Ca atoms whereas the comparison with OcDH/NADH
complex is 1.5 A ˚ over 399 Ca atoms.
In both structures (agmatine and L-arginine complex) Arg324
forms a salt bridge with the pyrophosphate moiety of NADH. As a
consequence of the domain movement, the distance of this salt
bridge is reduced from 4.3 A ˚ (NADH complex) to 3.8 A ˚ (L-
arginine and agmatine complex), which of course will strengthen
this interaction.
As stated above, the conformational change observed here as
well as the reorientation of the his5-tag was never detected in the
crystals of the OcDH/NADH complex. Furthermore, data sets of
unsuccessful soaking of agmatine into the crystals revealed
structures identical to the OcDH/NADH complex with no
reorientation of the his5-tag or domain closure and these data
sets had no significant change in the unit cell axis. This suggests,
that a significant reorientation of the two domains occurs during
the process of binding of agmatine into the crystals. Obviously the
conformational change is tolerated by the crystal lattice and not
dictated by packing forces. Further support for this interpretation
comes from a closer inspection of the his5-tag that protrudes in
both structures (OcDH/NADH and OcDH/NADH-agmatine
complex) in the cleft between both domains. In the OcDH/
NADH complex water molecules establish a network of interac-
tions between the protein and the his5-tag [14]. In contrast direct
interactions between the his5-tag and OcDH are observed in the
OcDH/NADH-agmatine complex similar to the ones observed in
the OcDH/NADH-L-arginine complex. This demonstrates that
the substrate induced conformational change in the protein
generates a new set of interactions that are only possible in the
ternary complex. Due to this rearrangement, the diffraction
quality of these crystals decreased due to the ligand-induced
rotation, which is reflected in a lower resolution (2.1 A ˚ for the
OcDH/NADH complex and 2.8 A ˚ for OcDH/NADH-agmatine
complex, respectively).
Discussion
Several studies have been undertaken to gain insights into the
kinetic mechanism of the reductive condensation of octopine and
its reversible oxidation. The results of spectrometric and
fluorometric studies indicated that NADH binds initially to the
apo enzyme, followed by L-arginine forming the OcDH/NADH-
L-arginine complex [21]. These results questioned the results of
Schrimsher and Taylor who proposed, based on kinetic and
inhibitor studies, that NADH binds first followed by a random
binding of L-arginine and pyruvate [12]. Based on structural
evidence a binding sequence of NADH, L-arginine and pyruvate
leading to the active complex was suggested [10]. In order to
clarify these discrepancies and also to answer the question how the
reduction of pyruvate to lactate instead of the formation of
octopine is prevented, we gained additional information on the
substrate binding mechanism employing solution NMR and X-ray
crystallography.
The NMR titrations demonstrated that neither addition of L-
arginine nor of pyruvate to the apo enzyme did induce any
differences in amide cross peaks in the absence of NADH.
Obviously, NADH respectively NAD
+ must bind first to OcDH
which has already been shown for some other dehydrogenases
[22]. Indeed, L-arginine binds to OcDH when pre-saturated with
NADH as demonstrated by the shift of amide cross peaks in the
corresponding NMR experiments. The dissociations constants for
NADH and NAD
+ are in good agreement with the binding
Figure 4. Inhibition study of OcDH by using agmatine. A Lineweaver-Burk plot is shown for the activity of OcDH at fixed L-arginine
concentration and increasing levels of agmatine. The double reciprocal representation shows that all concentration of the inhibitor analysed crossed
the y-axis at the same point, which indicates the OcDH is inhibited by agmatine in a competitive manner.
doi:10.1371/journal.pone.0012312.g004
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Olomucki who used fluorometric studies obtaining values of
0.02 mM and 0.38 mM for NADH and NAD
+ respectively [8].
The dissociation constant for L-arginine is not reported in
literature so far. However during the recovery of P. maximus the
L-arginine concentrations are in the mM range in this organism.
Therefore the measured Kd of 4.160.3 mM for L-arginine to
OcDH is in accordance with the in vivo levels of L-arginine [4].
This demonstrates that L-arginine is capable of binding to the
binary OcDH/NADH complex. However, no shifts of amide cross
peaks were observed when pyruvate was added to a NADH-
saturated enzyme. This is in agreement with biochemical data of
OcDH were no activity is observed when pyruvate is added to
OcDH/NADH [9,10].
The results of the NMR-spectroscopic investigations not only
suggest a clear order and seuqnece of substrate binding, but also
show that L-arginine binding is associated with a conformational
change in solution. This confirms the conformational change
substantiated in the X-ray structure of the substrate bound
complex [10].
NADH binding introduces a small conformational change, as it
is known for most dehydrogenases [23]. Only a few amide cross
peaks shift in the NMR spectra and the crystal structure evidently
shows that only a slight conformational change is required to
stabilize the orientation of both domains towards each other via
the interaction of Arg324 with NADH, thereby generating the
binding site for the second substrate, L-arginine as seen in the
published crystal structure [10].
Figure 5. Structural comparison A) Superposition of the OcDH/NADH (white) and the OcDH/NADH-agmatine (blue) complexes
highlight the inward rotation of domain II. B) Superposition of the agmatine binding site. Shown is the binding site in the OcDH/NADH
complex (white) and from the OcDH/NADH-agmatine complex (blue).the reorientation of the his5-tag is shown by the representation of both his5-tag
(red for the OcDH/NADH complex and green for OcDH/NADH/-agmatine complex) C) Stereoview of the agmatine-binding pocket of OcDH. The
agmatine-binding pocket is located in domain II, directly at the N-terminal helix-kink-helix motif of domain II. Agmatine is coordinated by the side
chain Trp278, backbone interactions with Tyr208 (domain II) and Glu142 (domain I). NADH is bound in a canonical fashion to the Rossman fold, while
interactions of the amide side chain of the nicotine amide ring with the backbone atoms of Cys148 (domain I) ensure the syn-conformation. The
electron density of an omit map contoured at 1 s for agmatine is shown as blue mesh.
doi:10.1371/journal.pone.0012312.g005
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not be detected through a shift of amide cross peaks in the NMR
experiments. The binding site of pyruvate is in proximity to the
NADH allowing hydride transfer. This however would lead to the
formation of lactate, which cannot be detected in vivo as well as in
vitro experiments. As mentioned before, this leads to the conclusion
that L-arginine binds prior to pyruvate and is the second substrate
that binds in a sequentially ordered mechanism. L-arginine
binding is associated with a conformational change, which
generates the binding site for pyruvate [10] and allows pyruvate
to be located in close proximity to NADH. A similar mechanism
was described for the bacterial N-(1-D-carboxylethyl)-L-norvaline
dehydrogenase (CENDH) from Athrobacter spec. by Britton et al.
[24]. In the CENDH mechanism the amino-acid substrate is
reported to bind to the enzyme/coenzyme complex before
pyruvate. In the above proposed sequential ordered mechanism,
the reduction of pyruvate to lactate without the need for L-
arginine is avoided, which is in line with the published data were
no lactate could be detected albeit in Pecten jacobaeus [25].
Since we were not able to perform a sequence specific
assignment of the amide cross peaks of OcDH via NMR we
investigated the conformational change further by an inhibitor,
namely agmatine, which is a L-arginine analog lacking the
carboxyl group. We crystallized and solved the structure of the
OcDH/NADH-agmatine complex. The his5-tag as well as the
coenzyme NADH has been essential for the crystalisation of
OcDH [14]. However the his5-tag binds in between both domains
and is localized near the L-arginine as well as the pyruvate binding
site. By soaking of the substrates into preformed crystals the
structures of both OcDH/NADH-substrate complexes were
solved and the binding sites revealed. Not only the binding sites
were verified by an extensive mutational analysis [10], but now the
conformational changes were also observed in solution by NMR
spectroscopy. OcDH-His5 in solution never appeared to form a
dimeric or higher oligomeric species, as analysed by size exclusion
chromatography or native gel electrophoresis (data not shown).
Furthermore a his-tag induced oligomerisation and a subsequent
conformational change would have been detected in the solution
NMR experiments. In all cases (apo enzyme, NADH and
substrates) the T2 relaxation rate did not change. The determined
T2 relaxation rate is in agreement with a monomeric OcDH
under the condition of the experiments, indicating that even at the
concentrations required for the NMR experiments OcDH remains
monomeric (data not shown). This suggests that the conforma-
tional change observed is not induced by the his5-tag but rather via
the addition of the inhibitor agmatine.
Here a similar conformational change was observed as in the
recently reported OcDH/NADH-L-arginine complex. This im-
plies that the carboxyl group of the L-arginine amino acid is not
responsible for the domain closure. OcDH has been shown to be
specific for L-arginine and any other amino acid reduces the
activity of OcDH by almost a factor of 100 [10]. Thus, the binding
of the side chain of L-arginine via interaction with both domains of
the protein is likely crucial for triggering conformational change
required to generate the bindings sites of the other substrates.
In the structure of the saccharopine dehydrogenase from
Saccharomyces cerevisiae the ternary complex model does not represent
the catalytically competent conformation of the enzyme as the
substrate and cofactor are too far apart for catalysis to occur (5.7 A ˚)
[13]. This suggests that a similar conformational change as seen in
OcDH is required during the reaction cycle. Besides, the saccharopine
dehydrogenase from Saccharomyces cerevisiae, also the alanine dehydro-
genase from Phormidium lapideum undergoes a conformational change
upon substrate binding which is a perquisite for its activity [26].
In summary, substrates of OcDH bind in an ordered sequential
manner. First NADH binds to OcDH followed by L-arginine. The
binding of the guanidinium headgroup of L-arginine induces a
conformational change, resulting in the formation of the pyruvate
binding site. This implies that the reduction of pyruvate can only
occur in the presence of L-arginine, which than forms octopine and
prevents lactate formation as earlier already observed [27]. Also the
structure of the OcDH/NADH-agmatine complex indicates that
the binding of the L-arginine side chain triggers the domain closure
of OcDH and not the carboxyl moiety of the amino acids, a
prerequisite for catalyzing octopine synthesis by OcDH.
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